Literature DB >> 7841896

The usefulness of nimodipine, an L-calcium channel antagonist, in the treatment of tinnitus.

E Davies1, E Knox, I Donaldson.   

Abstract

Thirty-one patients were drawn from a tinnitus clinic, screened for other medical problems and treated for 4 weeks with 30 mg nimodipine four times daily. Before and after treatment, the intensity of their tinnitus was assessed subjectively on a scale 1-10. Five patients reported to have a great improvement in their tinnitus whilst two claimed a worsening of the condition. Of the five positive responders, four were treated further with 30 mg nimodipine per day for 4 weeks and 60 mg per day for a further 4 weeks. During this treatment they were assessed more objectively by the determination of the minimal masking level using narrow band noise. There was a good correlation between the subjective and objective assessment of their responses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7841896     DOI: 10.3109/03005369409086559

Source DB:  PubMed          Journal:  Br J Audiol        ISSN: 0300-5364


  12 in total

Review 1.  Tinnitus.

Authors:  A Sismanis
Journal:  Curr Neurol Neurosci Rep       Date:  2001-09       Impact factor: 5.081

2.  Alteration of loosely bound calcium in the guinea pig organ of Corti after treatment with diltiazem as calcium channel blocker.

Authors:  U R Heinrich; J Maurer; W Mann
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

3.  PHARMACOLOGICAL TREATMENTS FOR TINNITUS: NEW AND OLD.

Authors:  R Salvi; E Lobarinas; W Sun
Journal:  Drugs Future       Date:  2009       Impact factor: 0.148

4.  Tinnitus psychopharmacology: A comprehensive review of its pathomechanisms and management.

Authors:  Michele Fornaro; Matteo Martino
Journal:  Neuropsychiatr Dis Treat       Date:  2010-06-24       Impact factor: 2.570

Review 5.  Emerging pharmacotherapy of tinnitus.

Authors:  Berthold Langguth; Richard Salvi; Ana Belén Elgoyhen
Journal:  Expert Opin Emerg Drugs       Date:  2009-12       Impact factor: 4.191

6.  Acoustic over-exposure triggers burst firing in dorsal cochlear nucleus fusiform cells.

Authors:  Nadia Pilati; Charles Large; Ian D Forsythe; Martine Hamann
Journal:  Hear Res       Date:  2011-11-07       Impact factor: 3.208

7.  Role of acamprosate in sensorineural tinnitus.

Authors:  Dinesh Kumar Sharma; Sharanjit Kaur; Jatinder Singh; Inderpal Kaur
Journal:  Indian J Pharmacol       Date:  2012-01       Impact factor: 1.200

Review 8.  Nimodipine in otolaryngology: from past evidence to clinical perspectives.

Authors:  D Monzani; E Genovese; L A Pini; F Di Berardino; M Alicandri Ciufelli; G M Galeazzi; L Presutti
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-06       Impact factor: 2.124

9.  Relationship Between Diet, Tinnitus, and Hearing Difficulties.

Authors:  Piers Dawes; Karen J Cruickshanks; Antonia Marsden; David R Moore; Kevin J Munro
Journal:  Ear Hear       Date:  2020 Mar/Apr       Impact factor: 3.570

10.  Effect of a fixed combination of nimodipine and betahistine versus betahistine as monotherapy in the long-term treatment of Ménière's disease: a 10-year experience.

Authors:  D Monzani; M R Barillari; M Alicandri Ciufelli; E Aggazzotti Cavazza; V Neri; L Presutti; E Genovese
Journal:  Acta Otorhinolaryngol Ital       Date:  2012-12       Impact factor: 2.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.